Novartis Aktie
112,10
EUR
-1,15
EUR
-1,02
%
104,08
CHF
-0,44
CHF
-0,42
%
Werbung
Novartis Aktie Analyse
| 15.07.05 | Novartis akkumulieren | Independent Research | |
| 15.07.05 | Novartis buy | Jyske Bank | |
| 14.07.05 | Novartis kaufen | Helaba Trust | |
| 14.07.05 | Novartis buy | SEB | |
| 14.07.05 | Novartis akkumulieren | Independent Research | |
| 13.07.05 | Novartis neutral | HypoVereinsbank | |
| 13.07.05 | Novartis outperform | Bear Stearns | |
| 12.07.05 | Novartis kaufen | Helaba Trust | |
|
Werbung
|
|||
| 12.07.05 | Novartis in-line | Goldman Sachs | |
| 11.07.05 | Novartis neutral | Bank Sarasin & Cie | |
| 08.07.05 | Novartis | Weberbank | |
| 05.07.05 | Novartis kaufen | JRC | |
| 01.07.05 | Novartis buy | Jyske Bank | |
| 22.06.05 | Novartis neutral | Bank Sarasin & Cie | |
| 17.06.05 | Novartis buy | Jyske Bank | |
| 17.06.05 | Novartis reduce | UBS | |
| 16.06.05 | Novartis neutral | Robert W. Baird | |
| 16.06.05 | Novartis | Weberbank | |
| 10.06.05 | Novartis halten | Fuchsbriefe | |
| 08.06.05 | Novartis neutral | HypoVereinsbank | |
| 07.06.05 | Novartis neutral | Bank Sarasin & Cie | |
| 03.06.05 | Novartis buy | Merrill Lynch | |
| 03.06.05 | Novartis | Der Aktionärsbrief | |
| 02.06.05 | Novartis neutral | Bank Sarasin & Cie | |
| 02.06.05 | Novartis above average | Caris & Company | |
| 01.06.05 | Novartis Above Average | Caris & Company | |
| 27.05.05 | Novartis buy | Jyske Bank | |
| 20.05.05 | Novartis | JRC | |
| 20.05.05 | Novartis | JRC | |
| 10.05.05 | Novartis Buy | Smith Barney Citigroup | |
| 27.04.05 | Novartis Sector Perform | Vontobel | |
| 25.04.05 | Novartis Kaufen | Hamburger Sparkasse | |
| 22.04.05 | Novartis Outperform | Goldman Sachs | |
| 22.04.05 | Novartis Overweight | Lehman Brothers | |
| 22.04.05 | Novartis Hold | SEB | |
| 22.04.05 | Novartis Kaufen | NATIONAL-BANK | |
| 21.04.05 | Novartis Kaufen | Helaba Trust | |
| 21.04.05 | Novartis Buy | Merrill Lynch | |
| 21.04.05 | Novartis Akkumulieren | Independent Research | |
| 21.04.05 | Novartis Neutral | Sarasin Research | |
| 19.04.05 | Novartis Buy | Merrill Lynch | |
| 19.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 18.04.05 | Novartis Neutral | JP Morgan | |
| 18.04.05 | Novartis Outperform | Goldman Sachs | |
| 15.04.05 | Novartis Neutral | HypoVereinsbank | |
| 15.04.05 | Novartis Kaufen | Helaba Trust | |
| 15.04.05 | Novartis Neutral | Sarasin Research | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Underperform | Credit Suisse First Boston | |
Werbung
Werbung